IMDA and Life Sciences Skillnet in conjunction with National University of Ireland Galway have developed a new Diploma in Sales and Marketing for Medical Technologies. This part time programme has been uniquely developed by the IMDA's Sales and Marketing Working Group, NUI Galway Department of Marketing and BioInnovate Ireland, and runs over one academic year with lectures in semester 1 taking place on campus on consecutive Fridays. The programme content is extensive and varied with four taught modules in semester 1 and an applied project in semester 2. Prior to commencement of these taught modules an induction day will take place on campus. The Diploma offers the opportunity to use the knowledge and skills acquired through the taught modules to the applied sales & marketing project.The course is suitable for professionals who wish to embark on a career in medical technology sales and marketing. Most of the content will be delivered under the direction of the J.E. Cairnes School of Business and Economics at NUI, Galway and BioInnovate Ireland. For more information download the programme brochure.
Ireland has ranked 3rd in the recent European Commission's proposed new indicator of Innovation Output, and was was described as a 'top performer, particularly in the translation of innovative ideas into commercial reality. For the full story please visit Silicon Republic.
BioInnovate Ireland, in conjunction with Stanford University, hosted the inaugural European meeting of the Biomedical Engineering Innovation, Design and Entrepreneurship Alliance (BME-IDEA) on June 14th at NUI Galway. The focus of this active-participation workshop was the sharing of ideas and experiences among faculty and colleagues involved in programmes focused on design, innovation and entrepreneurship in the medtech space.
The workshop was attended by over 30 deletages from 15 different university programmes, including Stanford University, Northwestern University, Johns Hopkins University, Center for Technology in Medicine and Health (CTMH), Sweden, Bio-X Denmark, and Imperial College London.
BioInnovate Ireland hosted the end of year symposium for the 2012/2013 Fellowship year on May 31st 2013.
Dr Hanson Gifford of The Foundry was the keynote speaker for the event. In a panel Q&A session the 2012/2013 Fellows discussed the BioInnovate process and then individually discussed some examples of projects that are being taken forward after the programme. Wayne Allen, 2011/2012 BioInnovate Alum, presented on the current status of a project brought forward from the inaugural Fellowship year with the support of the Enterprise Ireland Commercialisation Fund.
In recognition of the tremendous growth in lifescience and healthcare within BRIC countries, BioInnovate Ireland sent two of this year's fellows on a fact-finding mission to India. The trip included a link with Standard Biodesign India and a chance to validate their Urology based need statements from a developing country standpoint while identifying opportunities for Irish med tech companies, startups and innovation providers. Ashwin Kher and Michael Morrissey, 2013 BioInnovate Ireland Fellows, gave their impressions on a trip that was a truly beneficial and provided a unique overview of the Indian health sector.
We began our BioInnovate mission at the All India Institute of Medical Sciences (AIIMS), Delhi. Professor Dogra (Head of Urology) and Professor Bajpai (Head of Pediatric Surgery) personally facilitated our visit to AIIMS. We spent two busy days at AIIMS interacting with a number of Departments and Urological Consultants, and were struck by the similarity of the procedures, standards of the theatres, and sheer number of patients that AIIMS accommodated on a daily basis. What's more, the medical devices available to physicians equaled anything we had seen in Ireland to date. As India's premier government medical institute, AIIMS has a large focus on research. AIIMS partners with the India Institute of Technology (IIT) to facilitate the Stanford Biodesign India program - the programme is located in the old Theatre Block within AIIMS. Biodesign interacts across the hospital and academic faculty in many of the medical disciplines to produce innovative medical technologies for the indigenous Indian market, and eventual export. The structure of the program is quite similar to the BioInnovate program, the primary difference being the initial target market for devices developed. Our interactions with the India Biodesign programme gave us an opportunity to test the needs we identified in Ireland from an emerging market perspective.
To get in touch with BioInnovate Ireland email us or see our contact details.
Learn about the Irish Medical Technology Sector by reading our key facts article.